| Seroprotection status |  | ||||
---|---|---|---|---|---|---|
Vaccine strain |  | Young cohort (n = 58) | Older cohort (n = 54) | p | ||
 |  | Placebo | B. longum + Gl-OS | Placebo | B. longum + Gl-OS |  |
 |  | n/N (%) | n/N (%) | n/N (%) | n/N (%) |  |
A/California/7/2009 (H1N1) | Before | 20/29 (69)a | 13/29 (45)a | 5/28 (18) | 1/26 (4) | < 0.001 |
After | 29/29 (100) | 27/29 (93)a | 22/27 (81) | 16/26 (62) | < 0.001 | |
A/Perth/16/2009 (H3N2) | Before | 10/29 (34) | 13/29 (45) | 8/28 (29) | 12/26 (46) | NS |
After | 26/29 (90) | 27/29 (93) | 25/27 (93) | 22/26 (85) | NS | |
B/Brisbane/60/2008 | Before | 4/29 (14) | 0/29 (0) | 4/24 (17) | 5/26 (19) | NS |
After | 28/29 (97) | 20/29 (76) | 14/27 (52) | 11/26 (42) | < 0.001 |